Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Perhexiline (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms HYPER
Most Recent Events
- 03 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 19 Jul 2012 United Kingdom Clinical Research Network reports accrual to date changed from 54% to 56%.
- 11 Aug 2011 Biomarkers information updated